🏆 Foundational Paper

A novel role for microtubules in apoptotic chromatin dynamics and cellular fragmentation.

Moss David K, Betin Virginie M, Malesinski Soazig D, Lane Jon D

📰 Journal of cell science 📅 2006 📊 139 citations

Abstract

Dramatic changes in cellular dynamics characterise the apoptotic execution phase, culminating in fragmentation into membrane-bound apoptotic bodies. Previous evidence suggests that actin-myosin plays a dominant role in apoptotic cellular remodelling, whereas all other cytoskeletal elements dismantle. We have used fixed cells and live-cell imaging to confirm that interphase microtubules rapidly depolymerise at the start of the execution phase. Around this time, pericentriolar components (pericentrin, ninein and gamma-tubulin) are lost from the centrosomal region. Subsequently, however, extensive non-centrosomal bundles of densely packed, dynamic microtubules rapidly assemble throughout the cytoplasm in all cell lines tested. These microtubules have an important role in the peripheral relocation of chromatin in the dying cell, because nocodazole treatment restricts the dispersal of condensed apoptotic chromatin into surface blebs, and causes the withdrawal of chromatin fragments back towards the cell centre. Importantly, nocodazole and taxol are both potent inhibitors of apoptotic fragmentation in A431 cells, implicating dynamic microtubules in apoptotic body formation. Live-cell-imaging studies indicate that fragmentation is accompanied by the extension of rigid microtubule-rich spikes that project through the cortex of the dying cell. These structures enhance interactions between apoptotic cells and phagocytes in vitro, by providing additional sites for attachment to neighbouring cells.

🔬 Techniques

🔭 Microscopes

Ti

💻 Software

✨ Fluorophores

🧪 Sample Preparation

🔬 Cell Lines

🏭 Microscope Brands

Leica Olympus Photometrics

🧪 Reagent Suppliers

📷 Detectors

💻 Software Details

Image Acquisition:
MetaMorph
Image Analysis:
Volocity MetaMorph

💾 Data Repositories

🏛️ Research Organizations (ROR)

Affiliated research institutions:

📋 Methods

✔ Verified methods section 1,070 words Read on PMC ↗

Reagents

Unless otherwise stated, reagents were obtained from Sigma (Poole, UK). Stock solutions of anisomycin (5 mg/ml), nocodazole (5 mg/ml), taxol (paclitaxel ™ , Calbiochem, Nottingham, UK: 20 mM), zVAD.FMK (Calbiochem: 50 mM), Ac-DEVD.AMC (Calbiochem: 10 mM), Y27632 (Calbiochem: 100 mM), propidium iodide (20 μg/ml), RNaseA (15 μg/ml), DAPI (4′,6-diamidino-2-phenylindole: 1 mg/ml), latrunculin A (Molecular Probes, Eugene, OR: 10 mM) and blebbistatin (Calbiochem: 100mM) were stored at −20ºC. Alexa 594 -annexin V, Alexa 488 -phalloidin and CellTracker green (CMFDA: 10 mM) were obtained from Molecular Probes.

Antibodies

The following antibodies were used: monoclonal anti-tubulin (B5-1-2: Sigma); polyclonal anti-cleaved PARP (Promega, Southampton, UK); monoclonal anti-tyrosinated α-tubulin (YL1/2: from John Kilmartin, Cambridge, UK); monoclonal anti-acetylated α-tubulin (C3B9) and polyclonal anti-pericentrin, both from Peter March (Manchester, UK); monoclonal anti-EB1 (Transduction Labs); polyclonal anti-ninein (from Mette Mogensen, UEA, UK ( Baird et al., 2004 )).

Constructs

The human high mobility group box 1 (HMGB1)-YFP construct has been described ( Lane et al., 2005 ). HMGB1-CFP was generated by sub-cloning into pECFP-N1 (Clontech). YFP-tubulin was obtained from Clontech. EB1-GFP was from the Morrison lab (University of Leeds, UK) ( Morrison et al., 2002 ). Human GFP-Centrin 2 ( White et al., 2000 ) was obtained from Jeff Salisbury (Mayo Clinic College of Medicine, MN). GFP-γ-tubulin was a gift from Steve Doxsey (University of Massachusettes, MA). Transient transfections were carried out using Fugene 6 (Roche, Lewes, UK) according to the manufacturer’s instructions.

Show full methods section

Reagents

Unless otherwise stated, reagents were obtained from Sigma (Poole, UK). Stock solutions of anisomycin (5 mg/ml), nocodazole (5 mg/ml), taxol (paclitaxel ™ , Calbiochem, Nottingham, UK: 20 mM), zVAD.FMK (Calbiochem: 50 mM), Ac-DEVD.AMC (Calbiochem: 10 mM), Y27632 (Calbiochem: 100 mM), propidium iodide (20 μg/ml), RNaseA (15 μg/ml), DAPI (4′,6-diamidino-2-phenylindole: 1 mg/ml), latrunculin A (Molecular Probes, Eugene, OR: 10 mM) and blebbistatin (Calbiochem: 100mM) were stored at −20ºC. Alexa 594 -annexin V, Alexa 488 -phalloidin and CellTracker green (CMFDA: 10 mM) were obtained from Molecular Probes.

Antibodies

The following antibodies were used: monoclonal anti-tubulin (B5-1-2: Sigma); polyclonal anti-cleaved PARP (Promega, Southampton, UK); monoclonal anti-tyrosinated α-tubulin (YL1/2: from John Kilmartin, Cambridge, UK); monoclonal anti-acetylated α-tubulin (C3B9) and polyclonal anti-pericentrin, both from Peter March (Manchester, UK); monoclonal anti-EB1 (Transduction Labs); polyclonal anti-ninein (from Mette Mogensen, UEA, UK ( Baird et al., 2004 )).

Constructs

The human high mobility group box 1 (HMGB1)-YFP construct has been described ( Lane et al., 2005 ). HMGB1-CFP was generated by sub-cloning into pECFP-N1 (Clontech). YFP-tubulin was obtained from Clontech. EB1-GFP was from the Morrison lab (University of Leeds, UK) ( Morrison et al., 2002 ). Human GFP-Centrin 2 ( White et al., 2000 ) was obtained from Jeff Salisbury (Mayo Clinic College of Medicine, MN). GFP-γ-tubulin was a gift from Steve Doxsey (University of Massachusettes, MA). Transient transfections were carried out using Fugene 6 (Roche, Lewes, UK) according to the manufacturer’s instructions.

Cell lines

Cells were maintained either in DMEM (A431; HeLa; SW13.Cl-2) or RPMI (Meg01; Jurkat; HL60; THP-1) each containing 10% foetal bovine serum, at 37°C and 5% CO 2 . A431 cells stably expressing YFP-tubulin were obtained following transient transfection by selecting positive clones after G418 treatment ( Lane et al., 2002 ). THP-1 cells (ECACC, Salisbury, UK) were differentiated into macrophages by incubating for 72 hours with 240 nm PMA (phorbol 12-myristate 13-acetate).

Apoptosis induction and drug treatments

Cells were induced into apoptosis by treatment with 5 μg/ml anisomycin or by UV irradiation (100 Jm −2 ( Lane et al., 2002 )). Inhibitors were used at the following final concentrations: latrunculin A (1.0 μM); Y27632 (100 μM); blebbistatin (12.5μm); nocodazole (5 μg/ml); taxol (20 μM); zVAD.FMK (50 μM).

Fluorescence microscopy and live-cell imaging

Wide-field fluorescence images were obtained using an Olympus IX-71 inverted microscope (60x Uplan Fluorite objective 0.65–1.25 NA, at maximum aperture) fitted with a CoolSNAP HQ CCD camera (Photometrics, Tucson, AZ) driven by MetaMorph software (Universal Imaging Corporation, Downington, PA). Confocal images were obtained using a Leica AOBS SP2 microscope (63x PLAPO objective 1.4 NA) at 0.2 μm z-steps. For immunofluorescence, cells were fixed in 2% paraformaldehyde (PFA: methanol-free, EM grade; TAAB, Aldermaston, UK) with 0.2% gluteraldehyde (TAAB), followed by permeabilisation with 0.1% Triton X-100, or in −20ºC methanol. To analyse apoptotic spikes by immunofluorescence, floating apoptotic A431 cells were spun on to poly-L-lysine coated coverslips (using a Shandon cytospin 3: 1000 rpm, 5 mins). Live-cell imaging was carried out using the Olympus IX-71 system. Halogen lamp illumination was used for both transmitted light and for epifluorescence to extend cell viability ( Lane et al., 2002 ). Cells were maintained in CO 2 -independent DMEM (Invitrogen, Paisley, UK), at 37°C in 3 cm cell imaging dishes (MatTek Co., Ashland, MA). FRAP investigations of YFP-tubulin expressing apoptotic cells were carried out using the Leica AOBS SP2 confocal microscope.

Analysis of apoptosis and cellular fragmentation UV-irradiated

A431 cells were incubated for 8 hours in the absence or presence of inhibitors. Apoptosis was assessed by measuring Ac.DEVD.AMC fluorescence in cell lysates (according to the manufacturer’s instructions). In parallel experiments, A431 cells were processed for immunoblotting using anti-cleaved PARP and anti-tubulin antibodies. To quantitate apoptotic bodies, CellTracker green-labelled A431 cells were fixed by adding a one third volume of 6% PFA to the culture medium, and passed through a 5 μm pore filter (Millipore, Watford, UK) by gravity flow ( Cline and Radic, 2004 ). Apoptotic cell fragments were cytospun on to poly-L-lysine coated coverslips as described above. The number of fragments in 10 random fields was assessed, in triplicate, in blind experiments by fluorescence and phase contrast microscopy. For flow cytometry, cells were fixed in ice-cold 70% ethanol, then incubated with 20 μg/ml propidium iodide in the presence of 15 μg/ml RNaseA for 1 hour at 37°C before being analysed using a FACScan (Becton Dickinson). Cellular fragmentation was expressed as the percentage of cells with sub-G1 DNA content. Phagocytosis assays PMA-differentiated THP-1 monocytes were adhered to glass coverslips in 6-well plates (750 000 cells/well). CellTracker-labelled apoptotic A431 cells were irradiated then incubated for 8 hours in the absence or presence of 5 μM nocodazole. Floating apoptotic cells were washed and 120 000 cells added to the THP-1 culture in 1 ml serum-free DMEM. After 30 mins co-incubation at 37°C, coverslips were washed extensively in PBS, and cells fixed in 2% PFA. The number of THP-1 macrophages interacting (bound and engulfed) and engulfing cell fragments was calculated in ten random fields in triplicate by fluorescence and phase contrast microscopy.

Electron microscopy Apoptotic

A431 cells were obtained by aspiration of culture medium from a dish of UV-irradiated cells, fixed by adding an equal volume of 4% gluteraldehyde, then processed for transmission electron microscopy as described previously ( Lane et al., 2005 ).

Analysis of apoptosis and cellular fragmentation UV-irradiated

A431 cells were incubated for 8 hours in the absence or presence of inhibitors. Apoptosis was assessed by measuring Ac.DEVD.AMC fluorescence in cell lysates (according to the manufacturer’s instructions). In parallel experiments, A431 cells were processed for immunoblotting using anti-cleaved PARP and anti-tubulin antibodies. To quantitate apoptotic bodies, CellTracker green-labelled A431 cells were fixed by adding a one third volume of 6% PFA to the culture medium, and passed through a 5 μm pore filter (Millipore, Watford, UK) by gravity flow ( Cline and Radic, 2004 ). Apoptotic cell fragments were cytospun on to poly-L-lysine coated coverslips as described above. The number of fragments in 10 random fields was assessed, in triplicate, in blind experiments by fluorescence and phase contrast microscopy. For flow cytometry, cells were fixed in ice-cold 70% ethanol, then incubated with 20 μg/ml propidium iodide in the presence of 15 μg/ml RNaseA for 1 hour at 37°C before being analysed using a FACScan (Becton Dickinson). Cellular fragmentation was expressed as the percentage of cells with sub-G1 DNA content.

Supplementary Material M1 M2 M3 M4 M5 M6 M7 S1 S2 S3 S4

📊 Figures

Figure 1

Microtubule organisation in late apoptotic HeLa cells

(A) Confocal image of apoptotic HeLa cells (6 hours anisomycin treatment) labelled with an anti-tubulin antibody (red) and DAPI (blue). Microtubules extend away from the body of the cell into chromati...

Figure 2

Formation of the apoptotic microtubule array in mid-to-late apoptosis

To the right, the proportion of HeLa cells possessing microtubules at various stages of apoptosis, based on the morphological characteristics shown to the left (only cells completely lacking microtubu...

Figure 3

Effects of apoptosis on centrosome integrity

(A) Confocal maximum projections of viable and apoptotic cells transiently expressing GFP-Centrin 2 and subsequently labelled with antibodies against u03b3-tubulin, ninein or pericentrin. In each zoom...

Figure 4

Microtubules are required for apoptotic cell fragmentation

(A) Influence of cytoskeletal inhibitors on apoptotic progression in UV-treated A431 cells, measured using the fluorogenic caspase substrate, Ac.DEVD.AMC (top) and by immunoblotting for cleaved PARP (...

Figure 5

Fluorescence microscopy of microtubule and actin distribution in apoptotic A431 cells

Confocal (Au2013C) and wide-field (D) fluorescence images of cytospin preparations of floating, UV-irradiated apoptotic A431 cells. (A, B) Apoptotic cells labelled with phalloidin (f-actin; green), an...

Figure 6

Microtubule and chromatin dynamics in apoptotic A431 cells

(A) Time-lapse imaging of anisomycin-treated A431 cells transiently co-expressing YFP-tubulin (green) and HMGB1-CFP (red). Alexa594-Annexin V labelling is false-coloured blue. Fluorescence frames are ...

Figure 7

TEM analysis of microtubule organisation in apoptotic A431 cells

(A) Bundles of closely packed, intersecting microtubules seen in longitudinal section (LS) in the body of an apoptotic A431 cell. (B) Detail of an area of cytoplasm at the base of an apoptotic spike. ...

Figure 8

Orientation and dynamics of apoptotic microtubules

(A) Confocal immunofluorescence imaging of EB1 distribution in an apoptotic A431 cell. EB1 puncta (red) are localised to the distal tips of microtubules (green) within apoptotic spikes. Bar = 10 u03bc...

Figure 9

Spikes enhance interaction between apoptotic cells and phagocytes

(A) Proportion of THP-1 macrophages interacting (bound and engulfed) and engulfing apoptotic A431 cells. Target cells were generated in the absence or presence of nocodazole. Shown are means (u00b1S.E...

Figure images are served from the NIH/NLM PubMed Central Open Access Subset or Europe PMC; copyright remains with the publishers and authors.

🏛️ Imaging Facility

🏛️ University of Bristol

💬 Discussion

0 comments

No comments yet. Be the first to start a discussion!

Leave a Comment

MicroHub Assistant